Send mail to Author

A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer : results of the PELICAN study (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _____     _____     _  _    __   __    _____     ______  
 |__  //   |  ___||  | \| ||  \ \\/ //  |__  //   /_   _// 
   / //    | ||__    |  ' ||   \ ` //     / //     -| ||-  
  / //__   | ||__    | .  ||    | ||     / //__    _| ||_  
 /_____||  |_____||  |_|\_||    |_||    /_____||  /_____// 
 `-----`   `-----`   `-` -`     `-`'    `-----`   `-----`
 


Back to frontdoor view

OPUS4 Logo